touchPODCAST

Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control.

The multidisciplinary team

• Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada
• Prof. Dr. Falk Bechara - Ruhr University Bochum, Germany
• Dr. Daniel Stein - George Washington University, Washington, DC, USA

This touchPODCAST is for HCPs only.

This activity is supported by an independent medical education grant from UCB.

Jointly provided by Partners for Advancing Clinical Education and touchIME.

touchIME is an EBAC® accredited provider. 

For further information visit our website: 

touchDERMATOLOGY.com and touchIMMUNOLOGY.com

Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss the medical and surgical decision-making challenges in perineal and genital HS, including common diagnostic pitfalls, how to integrate medical and surgical treatment, and the unique role of urology in managing complex disease. 

The multidisciplinary team

• Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada
• Prof. Dr. Falk Bechara - Ruhr University Bochum, Germany
• Dr. Daniel Stein - George Washington University, Washington, DC, USA

This touchPODCAST is for HCPs only.

This activity is supported by an independent medical education grant from UCB.

Jointly provided by Partners for Advancing Clinical Education and touchIME.

touchIME is an EBAC® accredited provider. 

For further information visit our website: 

touchDERMATOLOGY.com and touchIMMUNOLOGY.COM

Dr. Melinda Gooderham and Dr. Jillian Kerry discuss the unique challenges of hidradenitis suppurativa in women, including vulvar disease, hormonal influences, pregnancy, and the importance of collaboration between dermatology and obstetrics and gynecology.

The multidisciplinary team

• Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada
• Dr. Jillian Kerry - University of Saskatchewan, Saskatoon, Canada

This touchPODCAST is for HCPs only.

This activity is supported by an independent medical education grant from UCB.

Jointly provided by Partners for Advancing Clinical Education and touchIME.

touchIME is an EBAC® accredited provider. 

For further information visit our website: 

touchDERMATOLOGY.com and touchIMMUNOLOGY.COM

Dr. Melinda Gooderham and Prof. Dr. Falk Bechara discuss opportunities for earlier recognition and referral of hidradenitis suppurativa, including key clinical clues, referral pathways, and the impact of diagnostic delay. A patient perspective highlights the importance of timely diagnosis and coordinated care.

The multidisciplinary team

• Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada
• Prof. Dr. Falk Bechara - Ruhr University Bochum, Germany

This touchPODCAST is for HCPs only.

This activity is supported by an independent medical education grant from UCB.

Jointly provided by Partners for Advancing Clinical Education and touchIME.

touchIME is an EBAC® accredited provider. 

For further information visit our website: 

touchDERMATOLOGY.com and touchIMMUNOLOGY.COM

touchEXPERT FOCUS for touchINFECTIOUS DISEASES

Listen to a series of short interviews with three leading experts discussing preference-sensitive care for people living with HIV. Faculty consider the evolving landscape of simplified ART options, including long-acting injectable regimens, and provide practical strategies to align treatment choices with individual goals and preferences. They also discuss the value and feasibility of integrating patient-reported outcome assessments into routine care for people living with HIV.

The experts:

• Prof. Chloe Orkin – Barts Health NHS Trust and Queen Mary University of London, UK
• Dr. Brenda Crabtree-Ramirez – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
• Prof. Jürgen Rockstroh – HIV Outpatient Clinic, University of Bonn, Bonn, Germany

This touchPODCAST is for healthcare professionals outside of the UK.

This activity is funded by an independent medical education grant from ViiV Healthcare.

This activity is provided by touchIME.

For further information visit our website: https://touchinfectiousdiseasesime.org/empowering-choice-in-hiv/

 

touchEXPERT FOCUS for touchNEUROLOGY, touchIMMUNOLOGY, touchOPHTHALMOLOGY 

 

Dr. Eoin Flanagan shares his expert insights on myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and how to distinguish it from other demyelinating diseases like multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-positive NMOSD). As part of the interview, Dr. Flanagan describes MOGAD’s pathogenesis and explains how to achieve an early accurate diagnosis using the latest diagnostic frameworks.

 

The expert

• Dr. Eoin Flanagan, Mayo Clinic, Rochester, MN, USA

 

This activity is funded by an independent medical education grant from UCB.

It is jointly provided by USF Health and touchIME.

 

This touchPODCAST is for healthcare professionals in the USA only.

 

For further information, please visit our websites: www.touchNEUROLOGY.com, www.touchIMMUNOLOGY.com, www.touchOPHTHALMOLOGY.com

touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.  

The multidisciplinary team

• Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA
• Allergist/Immunologist: Dr. Theo Gülen, Karolinska University Hospital, Stockholm, Sweden
• Hematologist: Dr. Tsewang Tashi, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA
  

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation. 

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.  

The multidisciplinary team

• Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA
• Allergist/Immunologist: Dr. Theo Gülen, Karolinska University Hospital, Stockholm, Sweden
• Hematologist: Dr. Tsewang Tashi, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA
  

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation. 

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.  

The multidisciplinary team

• Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA
• Dermatologist: Dr. Lauren Madigan, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA
  

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation. 

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com

touchEXPERT FOCUS for touchONCOLOGY

Listen to an interview with Dr. Deborah Wong as she shares her expert insights on the current evidence and latest guidelines for immune checkpoint inhibitor (ICIs) use in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). She also discusses how patient- and disease-specific factors can inform individualized treatment decisions.

The expert:
Dr. Deborah Wong, University of California, Los Angeles (UCLA), CA, USA

 

This activity is funded by an independent medical education grant from Coherus Oncology, Inc.

This activity is jointly provided by USF Health and touchIME.

This touchPODCAST is for HCPs in the USA only.

 

For further information, please visit our website: www.touchONCOLOGY.com